ABSTRACT cDNA clones encoding different human Ia antigen g3 chains were isolated by use ofa complementation-expression assay in Xenopus oocytes. The assay was based on two previous findings. First, oocytes injected with mRNA from a human B-cell line express HLA-DR antigen. The three intracellular DR chains are assembled in oocytes and can be immunoprecipitated with anti-DR monoclonal antibodies. Second, we have isolated cDNA clones encoding DR a and intermediate chains. In order to identify 13-chain cDNA clones, mRNA was hybrid-selected with pools of cDNA clones, mixed with mRNA for the a and intermediate chains, and injected into oocytes. We isolated two distinct clones that could select DR (-chain mRNA as demonstrated by assembly of the translation product with DR a chains and immunoprecipitation with DR-specific monoclonal antibodies. One clone is specific for a 13 chain of the DR locus. The other clone, much weaker in its ability to select DR mRNA, encodes another Ia-like 13 chain. Full-length cDNA clones corresponding to the DR and Ia-like 13 chains were isolated and compared. Cross-hybridization was detectable in the coding regions but not in the 3' untranslated regions. Distinct RNAs homologous to the DR and the Ia-like 13-chain clones were present in B cells but were undetectable in three T-cell lines.
HLA-DR antigens are highly polymorphic cell surface glycoproteins found primarily on B lymphocytes and macrophages. They are thought to play an important role in the immune response by regulating the interaction among antigen-presenting cells, T cells, and B cells (1) . They are also important in the stimulation of the mixed lymphocyte reaction, in allograft rejection, and in their linkage to disease susceptibility (2, 3) . Their tissue distribution as well as their biochemical nature suggest that they are the human equivalent of the mouse Ia antigens, encoded in the I region of the mouse H-2 complex (reviewed in ref. 4 ). HLA-DR antigens are therefore often referred to as human Ia antigens ( Fig. 1) .
At the cell surface, HLA-DR antigens are made up of two noncovalently linked subunits, the Mr 35,000 a chain and the Mr 29,000 ( chain (5) . The allelic polymorphism is restricted to the (3 chain (6) (7) (8) . Several genes may exist for HLA-DR (3 chains because structurally distinct (3 chains have been distinguished with monoclonal antibodies (9) . A third subunit-called "invariant" (10) , "y" (11) , or "intermediate" (12) -is associated intracellularly with DR antigens. It is thought to be involved in assembly or transport of DR antigens to the cell surface (11, 13) .
Serological studies of human Ta antigens have demonstrated
that, besides DR, other molecules (e.g., DC-1) exist with as yet undetectable or limited polymorphism. These molecules are coded for by genes in close linkage disequilibrium with the classical polymorphic DR locus (14) (15) (16) . Another locus, termed SB, which controls a secondary lymphocyte reaction has been shown to encode Ta antigens (17) . The existence of seven different (3 chains in a DR-homozygous cell line has been established biochemically (18) . A direct molecular analysis would help understand the relationship between these genes.
We showed previously that Xenopus oocytes injected with mRNA from the human B-cell line Raji translate and assemble DR antigens that can be immunoprecipitated with monoclonal antibodies (12) . A RNA fraction enriched for the three mRNAs encoding the a, intermediate, and f3 chains was isolated (12) . A cDNA clone encoding the DR a chain, as evidenced by sequence analysis, was isolated (19) . Another cDNA clone was isolated which most probably encodes the intermediate chain; its isolation and characterization will be described elsewhere. The availability of the assembly system in oocytes and ofcDNA clones encoding a and intermediate chains allowed us to screen for 13 cDNA clones by a complementation-expression assay using DR-specific monoclonal antibodies. Here we report on the isolation and comparison of several cDNA clones encoding distinct HLA-DR (3 chains as well as a (3 chain of another Ia-like locus.
MATERIALS AND METHODS
Preparation of RNA and of cDNA Clones. Cytoplasmic poly(A)+RNA from the human B-cell line Raji (DR 3,w6) was prepared and enriched for HLA-DR mRNA as described (12) . Poly(A)+RNA from other sources was prepared by homogenizing frozen cells or tissues in 4 M guanidium thiocyanate buffer as described (20) . The homogenate was added to a CsCl gradient and the RNA was pelleted as described for cytoplasmic Raji RNA (12) . Production ofcDNA clones from the enriched mRNA fraction and the construction of a library of size-selected cDNA clones have been described (19) .
Positive Hybrid-Selection of mRNA. Our protocol was modified from the original procedure ofGoldberg et al. (21 Knowing the sensitivity ofthe translation assay for DR mRNA injected into Xenopus oocytes (12) and the efficiency of the hybrid-selection procedure, we calculated that 1 83 cDNA clone in a pool of50 cDNA clones should be detectable. Eleven 1-cm2 filters, each loaded with 50 different cDNA clones, and one control filter with pBR322 were incubated with 300' ,g of poly(A)3RNA in 200 Al. Under these conditions, the molar mRNA/DNA coding strand ratio was 2:1 for a mRNA representing 0.02% of the mRNA population. In the subsequent rounds of screening, with either 10 clones or 1 clone per filter, recovery of 3-chain mRNA was higher because the DNA was in molar excess. Each sample was complemented with' mRNA for the a and intermediate chains, which had been selected from 25 ,ug of poly(A)+RNA under conditions of cDNA excess.
Injection of Xenopus oocytes with mRNA and detection of translation products by immunoprecipitation were performed as described, (12) . Anti-DR rabbit antiserum and monoclonal antibodies D1-12, D4-22, and BT 2.2 have been described (12, 22) .
DNA Labeling and Sequence Determination. Restriction fragments were extracted from acrylamide gels and purified over DEAE-cellulose columns (23) . Fragments were labeled either internally by the nick-translation procedure (24) or terminally with [a-32P]dNTP (Amersham) and Klenow DNA polymerase I (Boehringer Mannheim). Fragments subcloned in M13 vectors were analyzed by the procedure of Sanger et al. (25) .
Hybridizations. Dot hybridizations were performed as described (216). Filters were washed several times at 500C in 4x standard saline citrate (NaCI/Cit; 0.15 M NaCI/0.015 M sodium citrate) before a series of 30-min washes at the indicated stringencies. Gel-transferred' RNA bound to diazobenzyloxymethyl-paper was hybridized as described (27) and washed twice for 30 min at each of the following conditions: 50% formamide/5x NaCl/Cit/0.5% NaDodSO4 at 42°C; 50% formamide/2x NaCl/Cit/0.5% NaDodSO4 at 42°C; 5X NaCI/Cit/ 0.1% sodium pyrophosphate/0.5% NaDodSO4 at 65°C; lx NaCl/Cit/0.1% NaDodSO4 at 65°C; 0.2X NaCI/Cit/0. 1% NaDodSO4 at 65°C; and 0.1x NaCI/Cit/0.1% NaDodS04 at 650C. Filters were dehybridized by boilingfor 10 min in 2.5 mMTris HC1, pH 7.4/0.5 mM EDTA.
RESULTS
Five hundred fifty cDNA clones derived from a Raji mRNA fraction enriched for DR mRNA (12) were grouped in pools of 50. mRNA was selected with each pool by positive hybrid-selection, mixed with mRNA for the a and the intermediate chains, and injected into Xenopus oocytes. Each sample was immunoprecipitated with a pool of anti-DR monoclonal antibodies all directed against monomorphic determinants on the DR 3 chain. In 2 of 11 pools a small amount of DR antigen was synthesized in the injected'oocytes. Both positive pools were divided in five pools of 10 clones each and screened again with the complementation-expression assay. One offive pools in each group was again positive (Fig. 2) . A final round of screening identified cDNA clones 68-6 and 83-7 as the (3-chain clones. The (3 chain synthesized in oocytes injected with mRNA hybrid-selected with cDNA clone 83-7 was also immunoprecipitated with anti-DR monoclonal antibodies in absence ofcomplementation with a and intermediate chains (Fig. 3) . In contrast, cDNA clone 68-6 was much less efficient in selecting DR (,3chain mRNA and was not detected in the absence of complementation. This difference between 83-7 and 68-6 was reproduced in three separate experiments.
The size ofthe cDNA insert was 180 base pairs (bp) for clone 83-7 and 470 bp for clone 68-6. Two long cDNA clones hybridizing with 83-7 at high stringency were isolated from a library of size-selected cDNA clones derived from Raji poly(A)+RNA. Because 83-7 was able to select efficiently, at high stringency, DR ( mRNA, as evidenced by assembly with DR a chain in oocytes and immunoprecipitation with anti-DR monoclonal antibodies, we consider that these clones encode DR ,B chains. They were called DR ,B-1 and DR ,B-2 and were found to be similar by restriction enzyme analysis (Fig. 4) Fig. 5 .
A long cDNA clone was isolated from the Raji library by hybridization with 68-6. Because its restriction map was completely different from that ofthe DR clones, it was called Ia-like ,B31 (Fig. 4) . The DR and Ia-like clones were compared further by cross-hybridizations at varying stringencies (Fig. 6) Because Ia antigens are found primarily on B cells we tested whether the mRNA corresponding to the DR and the Ia-like / cDNA clones were also B-cell specific (Fig. 7) . Both DR /3-1 and Ia /3-1 hybridized to a RNA species of about 1,300 nucleotides that was expressed in two B-cell lines and in B cells from a patient with chronic lymphocytic leukemia but undetectable in three T-cell lines and in pancreas. A low level of DR /3 mRNA may be present in liver. In addition to the 1,300-nucleotide-long RNA, each cDNA clone hybridized to an additional and distinct minor RNA species. The DR ,&1 clone hybridized to a RNA 1,900 nucleotides long, whereas the Ia-like ,&1 clone hybridized to a RNA 1,650 nucleotides long. These longer transcripts are not nuclear RNA precursors because they were present in a cytoplasmic RNA preparation from Raji cells.
DISCUSSION
The strategy for the identification of HLA-DR (3-chain cDNA clones was based on two facts. First, Xenopus oocytes injected with mRNA from the human B-cell line Raji translate and assemble the a, intermediate, and ,B DR chains into a complex that can be recognized by anti-DR monoclonal antibodies (12) .
Second, we have isolated cDNA clones encoding the DR a chain (19 (28) in Uppsala and is shown here for comparison. The length of the mRNA has been determined experimentally (see ref.
12 and Fig. 7 ). The structure of the chain is derived from the sequence of the 198 NH2-terminal amino acids determined for a human Ia chain (18) . The alignment of the coding regions for the Ia-like clones is based on the sequence of the Uppsala /-1 clone (29); for the DR clones it is based on the sequence of one of our DR , / clones ( Fig. 5; unpublished data) . a.a., Amino acid. Ia 3') . The specific activity of the Ia 3' probe was lower than that of the others; therefore it gave weaker signals. The final washesforthedifferent horizontal rows ofspots were: a, 500C, 2x NaCl/ Cit, which is 430C below the tm of a DNA sequence with 50% G-C base pairs; b, 500C, O.1x NaCl/Cit, 240C below tm; c, 650C, 0.05x NaCl/ Cit, 5VC below tm; d, 500C, 10 mM Tris HCl, pH 7.4/1 mM EDTA, which corresponds to the final wash in the hybrid-selection procedure. equivalent ofthe mouse invariant chain (unpublished data), the intermediate chain (12) . Because no amino acid sequence is available for these chains, identification of the clones relied on the analysis of translation products. The screening for 1 cDNA clones was based on the prediction that the translation products of hybrid-selected 13 mRNA, mixed with mRNA for the a and intermediate chains, would assemble in the oocytes and could be immunoprecipitated with anti-DR monoclonal antibodies.
With this complementation-expression assay a DR 13-chain cDNA clone can be identified by two lines ofevidence. The first is assembly with DR a chain. Because there is only one a gene hybridizing with a cDNA clones at high stringency (19) , the hybrid-selected a mRNA will only encode DR a chain. Heterodimers of DR a chains with other P chains have not been observed in vivo (9, 15 68-6, in its ability to select DR 1 mRNA. We consider therefore that it encodes a DR 1B chain. Corresponding full-length clones were isolated. The sequence ofa cDNA clone derived from the mRNA of a DR 7,7 homozygous cell line shows high homology with the amino acid sequence of a human Ia 13 chain from a DR 2,2 homozygous line ( Fig. 5; ref. 18 ). This amino acid sequence was determined for the most abundant but undefined 13 chain (18) . We have obtained evidence for at least three DR 13chain genes in the DR 7,7 homozygous line (unpublished data). These DR 1-chain genes are homologous to but clearly distinct from other Ia-like 13-chain genes. The evidence is based on analysis of cDNA clones and of genomic DNA clones. Therefore, even if the amino acid sequence published by Kratzin et al. (18) is ofa DR 13 chain, the differences observed with our cDNA clone do not necessarily reflect allelic polymorphism. For the same reason, the two clones DR 1&1 and DR 13-2 isolated from the heterozygous line Raji (Fig. 4) (28) . The differences between the Uppsala 1-1 clone and our Ia-like 11 clone can be either allelic or nonallelic. 
